CTRI/2023/11/059814尚未招募4 期
Effect of dapagliflozin and metformin compared to metformin monotherapy on metabolic-regulating hormones in diabetic patients with obesity– A Randomized Controlled Trial - NI
Shobana0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male/female aged 18-60 years
- •2.Newly diagnosed T2DM patients as per the ADA diagnostic criteria 2022 – Hb A1c of 5.7–6.4%, fasting blood glucose of >125 mg/dl for metformin group
- •3.Uncontrolled T2DM patients who started newly add on therapy with dapagliflozin for metformin +dapagliflozin group
- •4.Body mass index (BMI) of = 25 kg/m2
排除标准
- •1.Diagnosed T2DM who is already on antidiabetic medication
- •2.BMI = 24.9 kg/m2
- •3.Type 1 diabetes mellitus.
- •4.History of diabetic ketoacidosis or hyperosmolar non-ketotic coma.
- •5.Hyperthyroidism.
- •6.Hypothyroidism.
- •7.Uncontrolled hypertension (blood pressure >150/90 mm Hg).
- •8.Recent 3 kg weight loss or gain in preceding month.
- •9.Any history of any serious hypersensitivity reaction to dapagliflozin or metformin
- •10.On any other SGLT-2 inhibitor
- •11.History of malignancy
- •12.Patient with severe UTI
研究者
相似试验
尚未招募
3 期
A study on the effect of Dapagliflozin and Metformin combination on Insulin resistance and cardiovascular disease risk factors in subjects with type II diabetes mellitusCTRI/2023/10/059034S Abissha
进行中（未招募）
1 期
Effects of glucose-lowering interventions in pre-diabetesEUCTR2015-001552-30-DKSteno Diabetes Center A/S160
招募中
不适用
Effects of dapaglifrogine and metoformine in patients with type 2 diabetes:a randomized controlled studyType 2 diabetesJPRN-UMIN000032296Yokohama City University100
招募中
3 期
Comparison of the effect of Metformin and Empagliflozin in treatment of prediabetic patients.Prediabetes.Abnormal glucose tolerance testR73.0IRCT20210926052602N1Kashan University of Medical Sciences100
招募中
1 期
Comparison of the effect Of Metformin and Pioglitazone on hypertriglyceridemia(Dyslipidemia)Condition 1: Hypertriglyceridemia. Condition 2: Metabolic syndrom.Pure hyperglyceridemiaMetabolic syndromeE78.1E88.81IRCT20230618058524N1Islamic Azad University68